← Back
$XLO All transactions

Xilio Therapeutics, Inc.

▲ BUY
5 / 10

Conviction

$ Value

$31K

Shares

45,000

Price

$1

Filed

Jun 18

Why this score? (5/10)
  • Open market buy (+3)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

Shannon James Samuel

Title

CIK

0001485417

Roles

Director

Transaction Details

Transaction Date

2025-06-16

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

45,000

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6799 to $0.6891 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6659 to $0.6991 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Filing Info

Accession No.

0001415889-25-017705

Form Type

4

Issuer CIK

0001840233

Shannon James Samuel's History

Date Ticker Type Value
2026-03-26 XLO $44K
2025-06-17 XLO $17K
2025-06-16 XLO $31K
2025-06-11 XLO A $0
2025-05-14 MNKD A $0

Other Insiders at XLO (90d)

Insider Bought Sold Last
Shannon James Samuel $44K 2026-03-26
Blanchard Cheryl R 2026-04-15